Article Versions Notes

Wu C-K, Chen L-W, Chang T-S, Tung S-Y, Lin C-Y, Hung C-H, Lu S-N, Lin C-L, Chen C-H, Hsu C-W, et al. The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir. Viruses. 2022; 14(2):362. https://doi.org/10.3390/v14020362

Wu, Cheng-Kun, Li-Wei Chen, Te-Sheng Chang, Shui-Yi Tung, Chun-Yen Lin, Chao-Hung Hung, Sheng-Nan Lu, Chih-Lang Lin, Chien-Hung Chen, Chao-Wei Hsu, and et al. 2022. "The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir" Viruses 14, no. 2: 362. https://doi.org/10.3390/v14020362

Wu, C.-K., Chen, L.-W., Chang, T.-S., Tung, S.-Y., Lin, C.-Y., Hung, C.-H., Lu, S.-N., Lin, C.-L., Chen, C.-H., Hsu, C.-W., Hu, T.-H., & Sheen, I.-S. (2022). The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir. Viruses, 14(2), 362. https://doi.org/10.3390/v14020362